SYK - Stryker Corp Stock Price, Fair Value and News

$348.19+8.60 (+2.53%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

SYK Price Action

Last 7 days

0.4%

Last 30 days

-6.2%

Last 90 days

-10.8%

Trailing 12 Months

6.3%

SYK RSI Chart

SYK Valuation

Market Cap

132.9B

Price/Earnings (Trailing)

44.39

Price/Sales (Trailing)

5.88

EV/EBITDA

32.77

Price/Free Cashflow

38.1

SYK Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

SYK Fundamentals

SYK Revenue

Revenue (TTM)

22.6B

Rev. Growth (Yr)

10.68%

Rev. Growth (Qtr)

17.15%

SYK Earnings

Earnings (TTM)

3.0B

Earnings Growth (Yr)

-52.23%

Earnings Growth (Qtr)

-34.53%

SYK Profitability

Operating Margin

63.91%

EBT Margin

15.45%

Return on Equity

14.51%

Return on Assets

6.97%

Free Cashflow Yield

2.62%

SYK Investor Care

Dividend Yield

0.93%

Dividend/Share (TTM)

3.24

Shares Dilution (1Y)

0.35%

Diluted EPS (TTM)

7.76

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	21.0B	21.4B	22.0B	22.6B
2023	19.0B	19.5B	19.9B	20.5B
2022	17.4B	17.6B	17.9B	18.4B
2021	14.7B	16.2B	16.7B	17.1B
2020	15.0B	14.1B	14.2B	14.4B
2019	13.9B	14.2B	14.5B	14.9B
2018	12.7B	13.0B	13.3B	13.6B
2017	11.8B	12.0B	12.1B	12.4B
2016	10.1B	10.5B	10.9B	11.3B
2015	9.7B	9.8B	9.8B	9.9B
2014	9.1B	9.3B	9.5B	9.7B
2013	8.7B	8.8B	8.9B	9.0B
2012	8.5B	8.5B	8.5B	8.7B
2011	7.5B	7.8B	8.1B	8.3B
2010	6.9B	7.0B	7.2B	7.3B

Get all data in R, Python etc through our Historical Stock Data APIs

About Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

CEO	Mr. Kevin A. Lobo
WEBSITE	stryker.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	51000

Stryker Corp Frequently Asked Questions

What is the ticker symbol for Stryker Corp? What does SYK stand for in stocks?

SYK is the stock ticker symbol of Stryker Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Stryker Corp (SYK)?

As of Tue Apr 22 2025, market cap of Stryker Corp is 132.86 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of SYK stock?

You can check SYK's fair value in chart for subscribers.

Is Stryker Corp a good stock to buy?

The fair value guage provides a quick view whether SYK is over valued or under valued. Whether Stryker Corp is cheap or expensive depends on the assumptions which impact Stryker Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for SYK.

What is Stryker Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 22 2025, SYK's PE ratio (Price to Earnings) is 44.39 and Price to Sales (PS) ratio is 5.88. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. SYK PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Stryker Corp's stock?

In the past 10 years, Stryker Corp has provided 0.136 (multiply by 100 for percentage) rate of return.